Published on January 6, 2010 at 5:48 AM
Bio-Rad Laboratories, Inc. (NYSE: BIO) and
(NYSE: BIO.B), a multinational manufacturer and distributor of life science
research and clinical diagnostics products, announced today that it has
completed the purchase of certain diagnostics businesses of Biotest AG,
including its diagnostics products in the areas of blood transfusion
testing, transplantation, and infectious diseases for 45 million euros.
Bio-Rad signed a definitive agreement to acquire these diagnostics
businesses of Biotest on October 23, 2009.
"We are pleased with the opportunity to expand our product offering in the
area of immunohematology," said Norman Schwartz, Bio-Rad President and CEO.
"Integrating Biotest diagnostics products into our current offering will
further strengthen Bio-Rad's position in this area and enable us to provide
our customers, including those in the U.S., with a broader range of
products and services."
SOURCE: Bio-Rad Laboratories